International consensus (ICON) on treatment of Ménière's disease

• Published in: European annals of otorhinolaryngology, head and neck diseases head and neck diseases, 2018-02, Vol.135 (1), p.S29-S32
• Main Authors: Nevoux, J., Barbara, M., Dornhoffer, J., Gibson, W., Kitahara, T., Darrouzet, V.
• Format: Article
• Language: English
• Subjects: International consensus; Ménière's disease; Treatment
• ISSN: 1879-7296; 1879-730X
• DOI: 10.1016/j.anorl.2017.12.006

To present the international consensus for recommendations for Ménière's disease (MD) treatment. Based on a literature review and report of 4 experts from 4 continents, the recommendations have been presented during the 21st IFOS congress in Paris, in June 2017 and are presented in this work. The recommendation is to change the lifestyle, to use the vestibular rehabilitation in the intercritic period and to propose psychotherapy. As a conservative medical treatment of first line, the authors recommend to use diuretics and Betahistine or local pressure therapy. When medical treatment fails, the recommendation is to use a second line treatment, which consists in the intratympanic injection of steroids. Then as a third line treatment, depending on the hearing function, could be either the endolymphatic sac surgery (when hearing is worth being preserved) or the intratympanic injection of gentamicin (with higher risks of hearing loss). The very last option is the destructive surgical treatment labyrinthectomy, associated or not to cochlear implantation or vestibular nerve section (when hearing is worth being preserved), which is the most frequent option.